CancerConnect
Top Stories
Newly Diagnosed
Treatment & Care
Survivorship
GIST

Ripretinib Treatment for Gastrointestinal Stromal Tumors

Read More

Newsletter Signup | Join Community | Cancer Types

GIST

FEATURED
COMMUNITY

Gleevec (Imatinib) Treatment Improves Survival in GISTs

Understand the optimal use of Gleevec in the management of GISTs. 10 Year survival data now available.

Cancer Connect

Gastrointestinal Stromal Tumors Newsletter

Stay Current With Gastrointestinal Stromal Tumors Treatment Advances & Connect with Others

TraceyS

SWOG Study Shows Strong Long-Term Survival Rates for Patients with GIST

1 in 4 Gleevec treated GIST patients has survived 10 years.

Cancer Connect

New Drug Shows Improved Outcomes for Patients with Advanced Metastatic Tumors

New Drug Shows Improved Outcomes for Patients with Advanced Metastatic Mid-gut Neuroendocrine Tumors

Cancer Connect

Stivarga Approved for Treatment of Advanced Gastrointestinal Stromal Tumors

Stivarga Approved for Advanced Gastrointestinal Stromal Tumors

Cancer Connect

Surgery in Responding Patients Feasible for GIST

Surgery in Responding Patients Feasible for GIST

Cancer Connect

Surgery for Residual GIST May Improve Outcomes

Surgery for Residual GIST May Improve Outcomes

Cancer Connect

Community